TY  - GEN
AU  - Mahlangu,Johnny
AU  - Powell,Jerry S
AU  - Ragni,Margaret V
AU  - Chowdary,Pratima
AU  - Josephson,Neil C
AU  - Pabinger,Ingrid
AU  - Hanabusa,Hideji
AU  - Gupta,Naresh
AU  - Kulkarni,Roshni
AU  - Fogarty,Patrick
AU  - Perry,David
AU  - Shapiro,Amy
AU  - Pasi,K John
AU  - Apte,Shashikant
AU  - Nestorov,Ivan
AU  - Jiang,Haiyan
AU  - Li,Shuanglian
AU  - Neelakantan,Srividya
AU  - Cristiano,Lynda M
AU  - Goyal,Jaya
AU  - Sommer,Jurg M
AU  - Dumont,Jennifer A
AU  - Dodd,Nigel
AU  - Nugent,Karen
AU  - Vigliani,Gloria
AU  - Luk,Alvin
AU  - Brennan,Aoife
AU  - Pierce,Glenn F
TI  - Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
SN  - 1528-0020
PY  - 2014///0318
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Child
KW  - Drug Administration Schedule
KW  - Factor VIII
KW  - pharmacokinetics
KW  - Hemophilia A
KW  - drug therapy
KW  - Hemorrhage
KW  - Humans
KW  - Immunoglobulin Fc Fragments
KW  - therapeutic use
KW  - Male
KW  - Middle Aged
KW  - Recombinant Fusion Proteins
KW  - Time Factors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2013-10-529974
ER  -